在 COVID-19 大流行期间，吸毒者获得医疗保健和减少伤害服务的机会。
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
机构信息
Department of Family Medicine, School of Medicine, Faculty of Health Sciences, University of Pretoria, South Africa (MJS); School of Anatomical Sciences, Faculty of Health Sciences, University of the Witwatersrand, South Africa (TC); School of Health Sciences, Waterford Institute of Technology, Ireland (FS); State Drug Dependence Treatment centre, Institute of Mental Health, Pt BDS University of health Sciences, Rohtak, India (SA); State Drug Dependence Treatment centre, Ain Shams University, Egypt (NAS); Department of Psychiatry, Teine Keijinkai Hospital, Japan (TS); Department of Psychiatry and Mental Health, Faculty of Health Sciences, University of Cape Town, South Africa (LD); Drug De-addiction and Treatment Centre and Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India (AG); Department of Psychological Medicine, University Malaya Centre of Addiction Sciences (UMCAS), Faculty of Medicine, University of Malaya, Malaysia (AY); Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand (WRA); Department of Mental Health and Addictions, Waikato District Health Board (WDHB), Hamilton, New Zealand (RV); Department of Psychiatry, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Hospital, Indonesia (KS); Patan Academy of Health Sciences, Nepal (BS); Department of Social and Community Health, School of Population Health, The University of Auckland. Auckland, New Zealand (RR); Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India (VLN); Center for Treatment of Drug Addiction, University Psychiatric Clinic Ljubljana, Slovenia (MD); AddiPsy, Lyon, France (EP); Department of Psychiatry, School of Medicine, Makerere University, Uganda (JLGO); Department of Psychiatry and Mental Health, Tribhuvan University Teaching hospital, Nepal (SBP); Faculty of Medicine and Pharmacy, Sidi Mohamed ben Abdellah University of Fez, Morocco (SB); ASL 4 Teramo, Department of Territorial Services, Services for Addictions (SerD), Italy (PG); Faculty of Health Sciences, University of the Witwatersrand, South Africa (NM).
出版信息
J Addict Med. 2020 Dec;14(6):e287-e289. doi: 10.1097/ADM.0000000000000753.
: Globally, there are concerns about access to healthcare and harm reduction services for people who use drugs (PWUD) during the coronavirus disease 2019 (COVID-19) pandemic. Members from the Network of Early Career Professionals working in Addiction Medicine shared their experiences of providing treatment to PWUD during the COVID-19 pandemic. Drawing on these qualitative reports, we highlight the similarities and discrepancies in access to services for PWUD in 16 countries under COVID-10 restrictions. In most countries reported here, efforts have been made to ensure continued access to services, such as mobilising opioid agonist maintenance treatment and other essential medicines to patients. However, due to travel restrictions and limited telemedicine services, several Network of Early Career Professionals working in Addiction Medicine members from lower-resourced countries experienced challenges with providing care to their patients during periods of COVID-19 lock-down. The insights provided in this commentary illustrate how the COVID-19 lock-down restrictions have impacted access to services for PWUD.
在全球范围内，人们对在 2019 冠状病毒病（COVID-19）大流行期间，药物使用障碍者（PWUD）获得医疗保健和减少伤害服务的情况表示担忧。从事成瘾医学的早期职业专业人员网络的成员分享了他们在 COVID-19 大流行期间为 PWUD 提供治疗的经验。根据这些定性报告，我们强调了在 COVID-19 限制下，16 个国家中 PWUD 获得服务的相似点和差异点。在本报告中所涉及的大多数国家，已经做出努力确保 PWUD 能够持续获得服务，例如为患者调动阿片类激动剂维持治疗和其他基本药物。然而，由于旅行限制和有限的远程医疗服务，来自资源较少国家的一些从事成瘾医学的早期职业专业人员在 COVID-19 封锁期间为患者提供护理方面遇到了挑战。本评论提供的见解说明了 COVID-19 封锁限制对 PWUD 获得服务的影响。
Zotero 插件